CHARGE POLARITY REVERSAL INVERSES THE SPECIFICITY OF NEUTRAL ENDOPEPTIDASE-24.11

被引:0
|
作者
BEAUMONT, A
BARBE, B
LEMOUAL, H
BOILEAU, G
CRINE, P
FOURNIEZALUSKI, MC
ROQUES, BP
机构
[1] CNRS,UNITE FORMAT & RECH SCI PHARMACEUT & BIOL 498,INSERM,U266,F-75270 PARIS 06,FRANCE
[2] UNIV MONTREAL,DEPT BIOCHIM,MONTREAL H3C 3J7,QUEBEC,CANADA
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Attempts to change enzyme specificity by charge polarity reversal have so far met with little success, probably due to a destabilization of the resulting ion pair in an environment naturally optimized for the inverted pair. In the zinc metallopeptidase neutral endopeptidase-24.11 EC 3.4.24.11), Arg102, involved in substrate binding, is probably located at the edge of the active site (Bateman, R. C., Jr., Kim, Y.-A., Slaughter, C., and Hersh, L. B. (1990) J. Biol. Chem. 265, 8365-8368; Beaumont, A., Le Moual, H., Boileau, G., Crine, P., and Roques, B. P. (1991) J. Biol. Chem. 266, 214-220). This environment may be favorable for polarity reversal, as in water the energies of reverse ion pairs would be identical. We show here that, while mutating Arg102 to Glu reduces the specificity of a C-terminally negatively charged substrate 16-fold, it increases that of a substrate with an optimally positioned positive charge 29-fold. The concept of charge polarity reversal can be extended to other zinc metallopeptidases, and the mutated enzyme could also have applications in the enantiomeric separation of unnatural amino acids.
引用
收藏
页码:2138 / 2141
页数:4
相关论文
共 50 条
  • [21] CHARACTERIZATION OF MULTIPLE FORMS OF ENDOPEPTIDASE-24.11
    VIDA, TA
    HERSH, LB
    FEDERATION PROCEEDINGS, 1986, 45 (06) : 1714 - 1714
  • [22] DEGRADATION OF LYSYLBRADYKININ BY ENDOPEPTIDASE-24.11 AND ENDOPEPTIDASE-24.15
    ROSENBAUM, C
    CARDOZO, C
    LESSER, M
    PEPTIDES, 1995, 16 (03) : 523 - 525
  • [23] STRUCTURE, DISTRIBUTION AND FUNCTION OF ENDOPEPTIDASE-24.11
    KENNY, AJ
    MATSAS, R
    TURNER, AJ
    DEVELOPMENTS IN NEUROSCIENCE, 1984, 17 : 257 - 264
  • [24] NONPEPTIDIC INHIBITORS OF NEUTRAL ENDOPEPTIDASE-24.11 .1. DISCOVERY AND OPTIMIZATION OF POTENCY
    DELOMBAERT, S
    BLANCHARD, L
    TAN, J
    SAKANE, Y
    BERRY, C
    GHAI, RD
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1995, 5 (02) : 145 - 150
  • [25] CHARACTERIZATION OF THE 5' REGION OF THE CD10 NEUTRAL ENDOPEPTIDASE-24.11 GENE
    HAOUAS, H
    MORELLO, D
    LAVENU, A
    BILLARD, M
    JASMIN, C
    BOUCHEIX, C
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1995, 207 (03) : 933 - 942
  • [26] PROBING THE ACTIVE-SITE OF NEUTRAL ENDOPEPTIDASE-24.11 BY SITE DIRECTED MUTAGENESIS
    HERSH, LB
    BATEMAN, RC
    JACKSON, D
    VIJAYARAGHAVAN, J
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1989, 197 : 37 - BIOL
  • [27] DESIGN AND SYNTHESIS OF AN ORALLY-ACTIVE MACROCYCLIC NEUTRAL ENDOPEPTIDASE-24.11 INHIBITOR
    MACPHERSON, LJ
    BAYBURT, EK
    CAPPARELLI, MP
    BOHACEK, RS
    CLARKE, FH
    GHAI, RD
    SAKANE, Y
    BERRY, CJ
    PEPPARD, JV
    TRAPANI, AJ
    JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (24) : 3821 - 3828
  • [28] REGULATION AND DIFFERENTIAL EXPRESSION OF NEUTRAL ENDOPEPTIDASE-24.11 IN HUMAN ENDOTHELIAL-CELLS
    GRAF, K
    KOEHNE, P
    GRAFE, M
    ZHANG, MH
    AUCHSCHWELK, W
    FLECK, E
    HYPERTENSION, 1995, 26 (02) : 230 - 235
  • [29] Neutral endopeptidase-24.11 (NEP) activity in human fibroblasts during development and ageing
    Kletsas, D
    Caselgrandi, E
    Barbieri, D
    Stathakos, D
    Franceschi, C
    Ottaviani, E
    MECHANISMS OF AGEING AND DEVELOPMENT, 1998, 102 (01) : 15 - 23
  • [30] INCREASED EXPRESSION OF NEPRILYSIN (NEUTRAL ENDOPEPTIDASE-24.11) IN RAT AND HUMAN HEPATOCELLULAR CARCINOMAS
    DRAGOVIC, T
    DEDDISH, PA
    TAN, FL
    WEBER, G
    ERDOS, EG
    LABORATORY INVESTIGATION, 1994, 70 (01) : 107 - 113